ESMO 2026 brings major breast cancer ADC data across HER2, TROP2, HER3, B7-H3 and Nectin-4. Here are 10 ADCs to watch in ...

Researchers in China are developing a cancer treatment that combines tiny carbon particles with iron, drawing on an idea from ...

Chinese researchers have developed an injectable treatment combining tiny carbon particles and iron to inhibit cancer growth, the South China Morning Post (SCMP) reported on the 17th. Professor Wang ...

A new review in Molecular Biology Reports maps how the apple-skin compound ursolic acid switches on cancer cell death, ...

Local Breast Cancer Screening & Care. On Oct. 21, Mesa County Public Health will host an educational event on breast health ...

Nanjing Leads Biolabs Co., Ltd. Class H ( (HK:9887) ) just unveiled an update.

A new study shows that sequencing tumor DNA in ascites, pleural fluid, cerebrospinal fluid, and pericardial effusions can ...

Oral presentation to highlight ATNM-400 antitumor activity across KRAS- and ALK-driven NSCLC models, building on earlier EGFR-mutant findings and supporting mutation-agnostic development Colorectal ...

Nanjing Leads Biolabs Co., Ltd. announced that the first patient has been dosed in an open-label, multicenter Phase Ib/II clinical trial evaluating opamtistomig (LBL-024), a PD-L1/4-1BB bispecific ...

Actinium Pharmaceuticals, Inc. announced three presentations, including an oral presentation and two e-posters, highlighting preclinical data supporting ATNM-400's broad potential at the 39th Annual ...

What Research Shows About Cancer Risk and Prevention / Breast Cancer, cancer, Cancer Prevention, Cancer research, cancer risk ...

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the first patient has been dosed in an open-label, multicenter Phase Ib/II clinical trial ...